State of Alaska Department of Revenue Sells 23,785 Shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

State of Alaska Department of Revenue cut its stake in Walgreens Boots Alliance, Inc. (NASDAQ:WBA) by 17.8% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 110,198 shares of the pharmacy operator’s stock after selling 23,785 shares during the quarter. State of Alaska Department of Revenue’s holdings in Walgreens Boots Alliance were worth $986,000 at the end of the most recent quarter.

Several other large investors have also recently made changes to their positions in WBA. New Covenant Trust Company N.A. purchased a new position in Walgreens Boots Alliance in the first quarter valued at about $35,000. Iron Horse Wealth Management LLC grew its position in shares of Walgreens Boots Alliance by 162.5% in the 2nd quarter. Iron Horse Wealth Management LLC now owns 2,100 shares of the pharmacy operator’s stock worth $25,000 after buying an additional 1,300 shares during the last quarter. Blue Trust Inc. raised its stake in shares of Walgreens Boots Alliance by 87.0% during the 2nd quarter. Blue Trust Inc. now owns 2,324 shares of the pharmacy operator’s stock worth $28,000 after acquiring an additional 1,081 shares in the last quarter. Continuum Advisory LLC lifted its position in Walgreens Boots Alliance by 71.2% during the second quarter. Continuum Advisory LLC now owns 2,453 shares of the pharmacy operator’s stock valued at $30,000 after acquiring an additional 1,020 shares during the last quarter. Finally, Strategic Investment Solutions Inc. IL acquired a new stake in Walgreens Boots Alliance in the second quarter valued at approximately $34,000. 58.59% of the stock is owned by institutional investors.

Walgreens Boots Alliance Stock Performance

Shares of WBA stock opened at $9.33 on Tuesday. The stock has a market cap of $8.07 billion, a PE ratio of -0.93, a price-to-earnings-growth ratio of 1.24 and a beta of 0.68. Walgreens Boots Alliance, Inc. has a 52-week low of $8.22 and a 52-week high of $27.05. The business has a 50-day simple moving average of $9.18 and a 200-day simple moving average of $12.38. The company has a quick ratio of 0.37, a current ratio of 0.68 and a debt-to-equity ratio of 0.67.

Walgreens Boots Alliance (NASDAQ:WBA) last released its quarterly earnings data on Tuesday, October 15th. The pharmacy operator reported $0.39 EPS for the quarter, topping the consensus estimate of $0.36 by $0.03. Walgreens Boots Alliance had a positive return on equity of 14.23% and a negative net margin of 5.85%. The business had revenue of $37.50 billion for the quarter, compared to analyst estimates of $35.75 billion. During the same quarter in the prior year, the firm posted $0.67 EPS. The business’s quarterly revenue was up 5.9% compared to the same quarter last year. On average, equities analysts expect that Walgreens Boots Alliance, Inc. will post 1.53 EPS for the current year.

Walgreens Boots Alliance Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, December 12th. Shareholders of record on Monday, November 18th will be given a $0.25 dividend. The ex-dividend date is Monday, November 18th. This represents a $1.00 dividend on an annualized basis and a dividend yield of 10.72%. Walgreens Boots Alliance’s dividend payout ratio (DPR) is currently -9.99%.

Analyst Ratings Changes

Several analysts have recently commented on the company. Bank of America decreased their price objective on Walgreens Boots Alliance from $11.00 to $7.50 and set an “underperform” rating for the company in a report on Wednesday, September 4th. Morgan Stanley lowered their price target on Walgreens Boots Alliance from $9.00 to $7.00 and set an “underweight” rating for the company in a report on Friday, October 11th. TD Cowen cut their price objective on shares of Walgreens Boots Alliance from $16.00 to $14.00 and set a “buy” rating on the stock in a report on Tuesday, October 22nd. Jefferies Financial Group lowered their target price on shares of Walgreens Boots Alliance from $19.00 to $9.00 and set a “hold” rating for the company in a research note on Wednesday, October 23rd. Finally, Barclays upped their price target on shares of Walgreens Boots Alliance from $7.00 to $8.00 and gave the company an “underweight” rating in a research note on Wednesday, October 16th. Four analysts have rated the stock with a sell rating, nine have given a hold rating and two have given a buy rating to the company’s stock. According to data from MarketBeat.com, Walgreens Boots Alliance has an average rating of “Hold” and an average price target of $12.88.

Walgreens Boots Alliance Profile

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.